Filling the need for trusted information on national health issues…

Blog Posts Discuss Use Of Bedaquiline To Treat Drug-Resistant TB In India, South Africa

The BMJ Opinion: Kanchan Mukherjee: Bedaquiline for multidrug resistant TB in India — at what cost?
Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India (6/20).

IDSA’s “Science Speaks”: Advocates hail South Africa bedaquiline recommendation, replacing toxic injection for patients with drug-resistant tuberculosis
Antigone Barton, senior editor and writer of “Science Speaks,” highlights South Africa’s decision to begin using bedaquiline to treat patients with drug-resistant TB and advocates’ reactions to the policy change (6/20).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.